WB and immunofluorescence analysis further corroborated the decrease in α‐SMA and Col1A1 expression in the skin of BLM‐SSc mice treated with anti‐IL‐17RA mAb (Figure 7F,G). Here, IL17RA is linked to systemic sclerosis.